Therapeutic Targeting of Non-Oncogene Dependencies in High-Risk Neuroblastoma

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-4117
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Alternative NHEJ Pathway Components Are Therapeutic Targets in High-Risk Neuroblastoma

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2015English

Polo-Like Kinase 1 Is a Therapeutic Target in High-Risk Neuroblastoma

Clinical Cancer Research
Cancer ResearchOncology
2010English

Maintenance DFMO Increases Survival in High Risk Neuroblastoma

Scientific Reports
Multidisciplinary
2018English

Therapeutic Innovations for Targeting Childhood Neuroblastoma: Implications of the Neurokinin-1 Receptor System

Anticancer Research
MedicineCancer ResearchOncology
2017English

Therapeutic Targeting of MZF1‐AS1 /PARP1/E2F1 Axis Inhibits Proline Synthesis and Neuroblastoma Progression

Advanced Science
Materials ScienceGeneticsMolecular BiologyBiochemistryEngineeringChemical EngineeringMedicineAstronomyPhysics
2019English

Determination of Synthetic Lethal Interactions in KRAS Oncogene-Dependent Cancer Cells Reveals Novel Therapeutic Targeting Strategies

Cell Research
Cell BiologyMolecular Biology
2012English

Distinct Signatures of the Immune Responses in Low Risk Versus High Risk Neuroblastoma

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2011English

Targeting Anaplastic Lymphoma Kinase in Neuroblastoma

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
ImmunologyAllergyMicrobiologyMedicineForensic MedicinePathology
2019English

Telomere Maintenance Is Pivotal for High-Risk Neuroblastoma

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy